Stock EHAB ENHABIT, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Enhabit, Inc.

Equities

EHAB

US29332G1022

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-18 pm EDT 		5-day change 1st Jan Change
10.11 USD -0.49% Intraday chart for Enhabit, Inc. -5.95% -2.32%
Mar. 08 UBS Adjusts Enhabit Price Target to $10 From $9.50, Maintains Neutral Rating MT
Mar. 08 North American Morning Briefing : Stock Futures -2- DJ

Evolution of the average Target Price on Enhabit, Inc.

Price target over the last 5 years

History of analyst recommendation changes

06b035256dd5edff61234b281115ee57.f2PT8BPAlgeW0JwGa0L3OcRiIuftyF0CIoSffHKdCHg.NDCGx1yNw3DdtcVcIQSCWrQnYdW1vzlOVbesLEfSUjYuKeKYJ63DNu6yqA~e3602acc657d76c097eac7d388c1d61d

Analyst Recommendations on Enhabit, Inc.

UBS Adjusts Enhabit Price Target to $10 From $9.50, Maintains Neutral Rating MT
UBS Upgrades Enhabit to Neutral From Sell, $9.50 Price Target MT
Jefferies Adjusts Price Target on Enhabit to $14 From $15, Maintains Buy Rating MT
TD Cowen Starts Enhabit With Market Perform Rating MT
Credit Suisse Adjusts Enhabit's Price Target to $12 From $15, Keeps Neutral Rating MT
Goldman Sachs Adjusts Price Target on Enhabit to $13 From $15, Maintains Neutral Rating MT
UBS Adjusts Enhabit Price Target to $9.50 From $11, Maintains Sell Rating MT
Goldman Sachs Starts Enhabit at Neutral With $15 Price Target MT
CJS Securities Initiates Coverage on Enhabit With Market Perform Rating, $18 Price Target MT
UBS Initiates Coverage on Enhabit With Sell Rating, $12 Price Target MT
Stifel Starts Enhabit at Buy With $17 Price Target MT
Credit Suisse Lowers Enhabit's Price Target to $15 From $19 on Further Mix Shift, Labor Cost Pressures; Keeps Neutral Rating MT
Oppenheimer Initiates Coverage on Enhabit With Perform Rating MT
Jefferies Initiates Enhabit at Buy with $20 Price Target MT
Credit Suisse Initiates Enhabit at Neutral with $19 Price Target, Says Mid-to-High Single-Digit Annual Organic Growth Possible Long-Term MT
RBC Cuts Price Target on Encompass Health to $66 From $82, Citing Enhabit Home Health & Hospice Spinoff, Maintains Outperform Rating MT
Citigroup Initiates Enhabit at Neutral With $17 Price Target MT
BofA Securities Initiates Enhabit at Underperform With $16 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
10.11 USD
Average target price
10.93 USD
Spread / Average Target
+8.10%
High Price Target
14 USD
Spread / Highest target
+38.48%
Low Price Target
8.5 USD
Spread / Lowest Target
-15.92%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Enhabit, Inc.

UBS
Jefferies & Co.
TD Cowen
Credit Suisse
Goldman Sachs
CJS Securities
Stifel Nicolaus
Oppenheimer
Citigroup
BofA Securities

Ratings for Enhabit, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. EHAB Stock
  4. Consensus Enhabit, Inc.